Literature DB >> 30053718

Cardiac and autonomic function in patients with Crohn's disease during remission.

Monika Zawadka-Kunikowska1, Joanna Słomko2, Maria Kłopocka3, Ariel Liebert3, Małgorzata Tafil-Klawe4, Jacek J Klawe2, Julia L Newton5, Paweł Zalewski2.   

Abstract

PURPOSE: The aim of the study was to assess cardiac and autonomic function in patients with Crohn's disease and explore their relation to disease duration using cardiovascular reflex tests.
MATERIALS AND METHODS: Cardiovascular parameters, baroreflex sensitivity, spectral-indices of short-term heart rate variability and blood pressure variability were compared between patients with Crohn's disease in remission (n = 30) and a control group (n = 29). Cardiac autonomic function was assessed during response to standing (tilt) and deep breathing test (expiration/inspiration ratio-E/I). Aortic pulse wave velocity, aortic augmentation index and central systolic blood pressure were measured oscillometrically.
RESULTS: At rest, Crohn's disease patients had significantly higher systolic (p = 0.03) and diastolic (p = 0.03) blood pressure, total peripheral resistance index (p = 0.003), sympathetic-parasympathetic ratio (p = 0.033) and lower baroreceptor effectiveness (p = 0.047), myocardial variables (stroke index; p = 0.03, cardiac index; p = 0.025, Heather index; p = 0.039, left ventricular ejection time; p = 0.038), as compared to controls. Orthostatic response to the tilt test in the Crohn's disease group and the control group was similar, no intergroup differences were observed for E/I ratio and autonomic parameters. In Crohn's disease patients, disease duration was negatively associated with baroreflex sensitivity and positively correlated with normalised high frequency heart rate variability, sympathetic-parasympathetic ratio at rest and post-tilt changes in Δsystolic blood pressure, p < 0.05. The control group had significantly lower central systolic blood pressure (p = 0.043) compared to Crohn's disease patients.
CONCLUSIONS: Crohn's disease patients in remission have preserved cardiac and autonomic function in response to cardiovascular reflex tests with a shift in cardiovascular autonomic regulation towards sympathetic predominate in the rest position.
Copyright © 2018 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic function; Blood pressure variability; Crohn’s disease; Heart rate variability

Mesh:

Year:  2018        PMID: 30053718     DOI: 10.1016/j.advms.2018.04.009

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  5 in total

Review 1.  The role of age-associated autonomic dysfunction in inflammation and endothelial dysfunction.

Authors:  Yunqiu Jiang; Andriy Yabluchanskiy; Jielin Deng; Faris A Amil; Sunny S Po; Tarun W Dasari
Journal:  Geroscience       Date:  2022-06-30       Impact factor: 7.581

2.  Heart rate variability and inflammatory bowel disease in humans: A systematic review and meta-analysis.

Authors:  Kyu-Nam Kim; Yao Yao; Sang-Yhun Ju
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

Review 3.  Inflammatory Bowel Disease: Role of Vagus Nerve Stimulation.

Authors:  Riccardo Fornaro; Giovanni Clemente Actis; Gian Paolo Caviglia; Demis Pitoni; Davide Giuseppe Ribaldone
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

4.  Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome.

Authors:  Alicia Fournier; Laurie Mondillon; Olivier Luminet; Fréderic Canini; Nicolas Mathieu; Anne Sophie Gauchez; Cécile Dantzer; Bruno Bonaz; Sonia Pellissier
Journal:  Front Psychiatry       Date:  2020-04-02       Impact factor: 4.157

5.  Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus.

Authors:  Branislav Milovanovic; Vlado Djajic; Dragana Bajic; Aleksandra Djokovic; Tatjana Krajnovic; Sladjana Jovanovic; Antonija Verhaz; Pedja Kovacevic; Miodrag Ostojic
Journal:  Front Neurosci       Date:  2021-06-21       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.